# Effect of resVida on Liver Fat Content

> **NCT01635114** · NA · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 112 (actual)

## Conditions studied

- Elevated Liver Fat Content and Insulin Resistance

## Interventions

- **DIETARY_SUPPLEMENT:** resveratrol
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01635114
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-12
- **Final completion:** 2015-09
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2016-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01635114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01635114, "Effect of resVida on Liver Fat Content". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01635114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*